Task: Answer the multiple-choice question.
Question: Which drug exhibits a -23.313% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cl.O=[N+]([O-])c1cc(CN(CCO)CCO)ccc1O
(b) FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
(c) CCCCn1c(=O)[nH]c(=O)c2c1nc(-c1ccc(OCC)cc1)n2CC
(d) CCOC(=O)c1sc(SC)nc1N
Answer: b. FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
4-[4-sulfanylidene-7-(trifluoromethyl)-5H-imidazo[2,1-c][1,4,2]benzodiazaphosphinin-4-yl]morpholine